Corpus Intelligence IC Memo — MCLAREN CENTRAL MICHIGAN 2026-04-26 14:30 UTC
IC Memo — MCLAREN CENTRAL MICHIGAN
Investment Committee Memorandum | MI | 49 beds | Grade C | EBITDA uplift $8.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MCLAREN CENTRAL MICHIGAN

CCN 230080 | ISABELLA, MI | 49 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MCLAREN CENTRAL MICHIGAN is a 49-bed under-performing / distressed in ISABELLA, MI with $118.9M in net patient revenue and a -35.3% operating margin. The hospital serves a payer mix of 26.2% Medicare, 4.5% Medicaid, and 69.3% commercial.

Thesis: Turnaround. Our ML models identify $8.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -35.3% to -27.9% (+736bps).

Net Revenue HCRIS$118.9M
Current EBITDA COMPUTED$-41.9M
Operating Margin COMPUTED-35.3%
Occupancy HCRIS40.4%
Revenue / Bed COMPUTED$2.4M
Net-to-Gross HCRIS31.4%
Distress Probability ML48.6%

2. Market Context & Competitive Position

163
MI Hospitals
-5.2%
State Median Margin
72
Comparable Hospitals

MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of -35.3% places it below the state median. Among 72 size-comparable peers (24-98 beds), the median margin is -3.4%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (24-98), prioritizing same-state peers. 72 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MCLAREN CENTRAL MICHIGAN (Target)MI49$118.9M-35.3%
TRINITY HEALTH LIVINGSTONMI42$200.4M15.2%
CHELSEA HOSPITALMI79$187.8M-1.1%
BEAUMONT HEALTH WAYNEMI97$180.7M-3.6%
OAKLAWN HOSPITALMI78$156.6M-12.4%
MYMICHIGAN MEDICAL CENTER ALMAMI49$142.2M-5.9%
SPECTRUM HEALTH UNITED MEMORIAMI45$129.4M9.7%
MCLAREN LAPEER REGIONMI92$127.1M-1.5%
DICKINSON COUNTY HEALTHCARE SYMI49$126.3M-4.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.5M+210bp18mo
Cost to Collect4.5%2.5%$2.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.4M+122bp9mo
Clean Claim Rate88.0%96.0%$76K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.5M
Cost to Collect
$2.4M
Denial Rate Reduction
$2.4M
A/R Days Reduction
$1.4M
Clean Claim Rate
$76K
Total EBITDA Uplift$8.8M
Current EBITDA$-41.9M
+ RCM Uplift+$8.8M
Pro Forma EBITDA$-33.2M
Current Margin-35.3%
Pro Forma Margin-27.9%
WC Released (1x)$4.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-64.5M$-189.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-64.5M$-228.9M0.00x-100.0%
Bull Case9.0x11.0x$-58.0M$-220.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-58.0M$-258.2M0.00x-100.0%
Bear Case11.0x10.0x$-70.9M$-211.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-70.9M$-256.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 72 hospitals with 24-98 beds
  • Same-state prioritization (n=73)
  • Comp margins: P25=-12.3% / P50=-3.4% / P75=7.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.